Citation Impact

Citing Papers

The Molecular Basis of Synergism between Carboplatin and ABT-737 Therapy Targeting Ovarian Carcinomas
2010
Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient–Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness
2019
Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?
2016
Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences
2009
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
Hypoxia Selectively Enhances Integrin α5β1 Receptor Expression in Breast Cancer to Promote Metastasis
2017 StandoutNobel
Tumor-Selective Response to Antibody-Mediated Targeting of αvβ3 Integrin in Ovarian Cancer
2008
β3-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer
2009
Repression of the miR‐17‐92 cluster by p53 has an important function in hypoxia‐induced apoptosis
2009
Physiology of BDNF: focus on hypothalamic function
2004
Molecular Architecture of the Mouse Nervous System
2018 Standout
On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape
2021 StandoutNobel
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation
2014
CXCR4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion through α5 and β3 Integrins
2006
The emerging role of lncRNAs in cancer
2015 Standout
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Guillain-Barré syndrome
2016 Standout
Biomedical applications of biodegradable polymers
2011 Standout
Rapid Optimization of Gene Delivery by Parallel End-modification of Poly(β-amino ester)s
2007
Molecular mechanisms of cisplatin resistance
2011 Standout
Blood–brain barrier destruction determines Fisher/Bickerstaff clinical phenotypes: an in vitro study
2013
Targeting apoptosis in cancer therapy
2020 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Hypoxia-induced collagen crosslinking as a mechanism for enhancing mechanical properties of engineered articular cartilage
2013
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
2006 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
The hallmarks of cancer
2012 Standout
Overexpression of Mcl-1L Splice Variant Is Associated with Poor Prognosis and Chemoresistance in Oral Cancers
2014
BCL-2 family isoforms in apoptosis and cancer
2019 Standout
Repair and tissue engineering techniques for articular cartilage
2014 Standout
Polycystic ovary syndrome
2016 Standout
Interorgan communication by exosomes, adipose tissue, and adiponectin in metabolic syndrome
2019
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
2020 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
The role of MicroRNAs in human cancer
2016 Standout
The Fibroblast Growth Factor signaling pathway
2015 Standout
Matrix Metalloproteinase 2-Integrin αvβ3 Binding Is Required for Mesenchymal Cell Invasive Activity but Not Epithelial Locomotion: A Computational Time-Lapse Study
2008
Fundamentals of cancer metabolism
2016 Standout
Reversible Kallmann Syndrome, Delayed Puberty, and Isolated Anosmia Occurring in a Single Family with a Mutation in the Fibroblast Growth Factor Receptor 1 Gene
2005
Rax regulates hypothalamic tanycyte differentiation and barrier function in mice
2013
Metabolic reprogramming and cancer progression
2020 StandoutScience
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Microproteomics by liquid extraction surface analysis: Application to FFPE tissue to study the fimbria region of tubo‐ovarian cancer
2013
α5β1 integrin recycling promotes Arp2/3-independent cancer cell invasion via the formin FHOD3
2015

Works of Soizic Dutoit being referenced

Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves αv integrins and the participation of MMP2
2004
Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis
2013
Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells☆
2007
Intraperitoneal linear polyethylenimine (L-PEI)-mediated gene delivery to ovarian carcinoma nodes in mice
2005
Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents
2005
Mesothelial vitronectin stimulates migration of ovarian cancer cells
2010
18F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer
2013
Plasma membrane reorganization links acid sphingomyelinase/ceramide to p38 MAPK pathways in endothelial cells apoptosis
2017
Molecular mechanism of hypoxia-induced chondrogenesis and its application in in vivo cartilage tissue engineering
2012
Expression of α V-associated integrin β subunits in epithelial ovarian cancer andits relation to prognosis in patients treated with platinum-based regimens
2005
Definitive evidence for the existence of morphological plasticity in the external zone of the median eminence during the rat estrous cycle: implication of neuro-glio-endothelial interactions in gonadotropin-releasing hormone release
1999
Identification of predictive factors of response to the BH3‐mimetic molecule ABT‐737: An ex vivo experiment in human serous ovarian carcinoma
2014
Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells
2009
Rankless by CCL
2026